Cellectis SA (CLLS)
3.00
-0.04
(-1.31%)
USD |
NASDAQ |
May 17, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Cellectis Cash from Financing (Quarterly): 41.58M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 41.58M |
September 30, 2023 | 1.688M |
June 30, 2023 | 19.82M |
March 31, 2023 | 19.78M |
December 31, 2022 | -5.042M |
September 30, 2022 | -4.12M |
June 30, 2022 | 2.63M |
March 31, 2022 | 7.677M |
December 31, 2021 | -1.423M |
September 30, 2021 | -3.682M |
June 30, 2021 | 42.84M |
March 31, 2021 | 9.79M |
December 31, 2020 | 12.68M |
September 30, 2020 | 16.54M |
June 30, 2020 | 0.001M |
March 31, 2020 | -1.899M |
December 31, 2019 | -1.025M |
September 30, 2019 | -0.838M |
Date | Value |
---|---|
June 30, 2019 | -0.721M |
March 31, 2019 | -1.278M |
December 31, 2018 | 0.164M |
September 30, 2018 | 1.913M |
June 30, 2018 | 230.93M |
March 31, 2018 | 3.485M |
December 31, 2017 | 0.953M |
September 30, 2017 | 39.18M |
June 30, 2017 | 0.849M |
March 31, 2017 | 0.282M |
December 31, 2016 | 0.055M |
September 30, 2016 | 0.1497M |
June 30, 2016 | -0.011M |
March 31, 2016 | 0.2913M |
December 31, 2015 | 0.433M |
September 30, 2015 | 1.057M |
June 30, 2015 | 218.77M |
March 31, 2015 | 0.327M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.042M
Minimum
Dec 2022
42.84M
Maximum
Jun 2021
8.225M
Average
1.688M
Median
Sep 2023
Cash from Financing (Quarterly) Benchmarks
DBV Technologies SA | -0.062M |
Biophytis SA | -- |
Genfit SA | -- |
Edap TMS SA | 0.3802M |
Adaptimmune Therapeutics PLC | 29.24M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 39.72M |
Cash from Investing (Quarterly) | -13.65M |
Free Cash Flow | -25.82M |
Free Cash Flow Per Share (Quarterly) | 0.6035 |
Free Cash Flow to Equity (Quarterly) | 37.77M |
Free Cash Flow to Firm (Quarterly) | 61.34M |
Free Cash Flow Yield | -15.07% |